Use of atypical antipsychotics in treatment of dementia declined after FDA warning

A warning issued by the Food and Drug Administration regarding the use of atypical antipsychotics for the treatment of dementia was associated with a significant decline in the use of these medications for treating dementia symptoms in elderly patients, according to a new study.

Read the whole article on Science Daily

More from Science Daily